By Pietro Lombardi
Grifols SA has reached an settlement with GIC, the sovereign wealth fund of Singapore, below which GIC will make investments round $1 billion within the Spanish bioscience firm’s U.S. subsidiary Biomat USA, Inc.
As a part of the settlement, the fund will take a minority stake within the U.S. enterprise and Grifols will maintain controlling its day-to-day operations.
The Spanish firm will use the cash to repay debt. The deal is topic to regulatory authorizations, together with from the Committee on Overseas Investments in america.
Write to Pietro Lombardi at email@example.com; @pietrolombard10